Treatments
490 articles
Failure is Not an Option
Christine Shaffer underwent chemotherapy and stereotactic body radiation therapy to shrink her tumor for surgery. She says failure is not an option.
Life With Pancreatic Cancer and on Clinical Trials
After a pancreatic cancer diagnosis, former basketball coach and GM Rob Babcock realized his best chance was with clinical trials.
Facing Life’s Challenges
The first time John Sherry faced pancreatic cancer he had part of his pancreas removed; the second time he had a Whipple procedure.
Strong Like a Dinosaur
Diagnosed with pancreatic cancer on her 40th birthday, Andrea Barkstrom receives chemotherapy and is living up to her motto: Strong Like a Dinosaur.
Genetic Testing Leads Me to a PARP Inhibitor Trial
Harvey Parker had genetic testing as part of his initial pancreatic cancer treatment. The BRCA2 mutation led him to a PARP inhibitor clinical trial.
The Importance of Family and Friends
Michael Florio has been able to count on his family and friends to get him to pancreatic cancer treatment and support him through a Whipple procedure.
Genomic Profiling of my Pancreatic Cancer Gave me a New Lease on Life
When standard treatment did not work for Roy Vinke, he had genomic profiling done. A mutation was found, changing his treatment plan.
Pancreatitis and Pancreatic Cancer Lead to Marathoning
Rob Stuardi had three bouts of pancreatitis before he was diagnosed with pancreatic cancer. He shares his joy of recovery running marathons to raise money for research.
A Novel Combination to Slow Pancreas Tumors that Cannot Be Surgically Removed
Can a combination of standard drugs, a PARP inhibitor, and intensity modulated radiation therapy to slow pancreatic tumor growth?
A New Approach to Treating Some Advanced Pancreatic Cancer Patients
A clinical trial uses PEGPH20, a synthetic form of a human enzyme, to make treatment more effective in pancreatic cancer patients with high tumor pressure.
Comparing a Standard Chemotherapy With and Without a PARP Inhibitor
A clinical trial compares standard chemotherapy with and without the addition of a PARP inihibitor, for patients whose pancreatic cancer is spreading again.
Electrical Pulses to Destroy Pancreatic Cancer Cells
A clinical trial looks the effectiveness of NanoKnife surgery on pancreatic cancer tumors that cannot be removed by traditional surgery.
Testing Standard Treatment Plus an Antibody to Shrink Pancreatic Tumors
Researchers are testing whether adding a monoclonal antibody to standard chemotherapy will make locally advanced pancreatic cancer qualify for surgery.
Using a Virus to Infect and Destroy Pancreatic Cancer Cells
A clinical trial tests the combination of standard chemotherapy plus a common cold virus that has been modified to kill cancer cells.
Two Types of Immunotherapy for Surgically Removable Pancreatic Cancer
A clinical trial compares the effectiveness of two different types of immunotherapy with standard treatment after pancreatic cancer surgery.